Leadership
Patrick Jiang
I am a current third-year undergraduate studying Computer Science and Math. When I am not thinking about Machine Learning, I like biking and working on bikes.
Rori Hoover
I'm a third year Biochemistry major. My hobbies include knitting, crochet and fostering kittens.
Kylie Hartana
I'm a fourth year undergraduate majoring in Biomedical Engineering. In my spare time, I enjoy reading, crocheting, and knitting.
Optogenetics/Luminescence Assays
Michelle Kim
I'm a sophomore studying computer science at Arizona State University. In my free time I enjoy reading and playing the piano!
Nicole Salazar
I'm a third year neuroscience major and am interested in doing more synthetic biology research in the future!
Brianna Botello
I am currently a third year biomedical engineering major. My hobbies include crochet and playing guitar!
Abigail Tang
I'm a junior studying Biological Sciences (Genetics, Cell, and Developmental Biology) and my research interests include understanding microorganisms and their underlying mechanisms, as well as synthetic biology.
Meghna Nair
I am a sophomore studying Biomedical Sciences and my research interests, alongside synthetic biology, include laboratory medicine and animal behavior!
Hardware
Tate Isaacs
I am a sophomore studying Applied Biological Sciences.I am very passionate about finding ways to automate synthetic biology workflows.
Ryan Crane
I am a second year biomedical engineering major with a data science minor. A fun fact about me is I am half Chinese!
Manal Ijaz
I am a sophomore studying Medical Microbiology and Global Health. My research interests largely pertain to medicine including microbes, immunology, and associated hardware.
Advisors
Benjamin Bartelle
My lab assays the diverse molecular signaling of whole living animals, using probes, reporters, and sensors derived from synthetic biology.
Chris Plaisier
My research group focuses on constructing gene regulatory networks from patient data that can be used to discover diagnostic and prognostic biomarkers as well as novel drug targets.